The government explained that the Novavax COVID-19 vaccine, which had signed a technology transfer contract with SK Bioscience on the 12th, could be supplied as soon as possible in June.

The release of this announcement raised controversy over the introduction of the Novavax vaccine, which has not yet been licensed abroad. Eventually, the conservative opposition party criticized using the people as clinical maruta.

As the controversy continued, the government was controversial over the introduction of the ax vaccine before approval the day after the announcement.

The government explained that the Novavax COVID-19 vaccine, which had signed a technology transfer contract with